BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Queensland Health
QuintilesIMS
Daiichi Sankyo
Chubb
Teva
Colorcon
McKinsey
Boehringer Ingelheim
Fuji

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 079069

« Back to Dashboard

NDA 079069 describes STAVUDINE, which is a drug marketed by Aurobindo Pharma, Hetero Labs Ltd Iii, Mylan, Mylan Labs Ltd, and Cipla Ltd, and is included in six NDAs. It is available from eight suppliers. Additional details are available on the STAVUDINE profile page.

The generic ingredient in STAVUDINE is stavudine. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the stavudine profile page.
Summary for 079069
Tradename:STAVUDINE
Applicant:Mylan
Ingredient:stavudine
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 079069
Medical Subject Heading (MeSH) Categories for 079069
Suppliers and Packaging for NDA: 079069
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
STAVUDINE stavudine CAPSULE;ORAL 079069 ANDA Mylan Pharmaceuticals Inc. 0378-5040 0378-5040-91 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-5040-91)
STAVUDINE stavudine CAPSULE;ORAL 079069 ANDA Mylan Pharmaceuticals Inc. 0378-5041 0378-5041-91 60 CAPSULE in 1 BOTTLE, PLASTIC (0378-5041-91)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength15MG
Approval Date:Dec 29, 2008TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Dec 29, 2008TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength30MG
Approval Date:Dec 29, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Queensland Health
Mallinckrodt
Dow
UBS
Colorcon
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot